Volume 64, Issue 5, Pages (November 2003)

Slides:



Advertisements
Similar presentations
Volume 60, Issue 3, Pages (September 2001)
Advertisements

Volume 64, Issue 5, Pages (November 2003)
Volume 62, Issue 4, Pages (October 2002)
Volume 60, Issue 3, Pages (September 2001)
Prabal K. Chatterjee, Salvatore Cuzzocrea, Christoph Thiemermann 
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Renal denervation prevents long-term sequelae of ischemic renal injury
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 65, Issue 2, Pages (February 2004)
Volume 78, Issue 10, Pages (November 2010)
Volume 63, Issue 3, Pages (March 2003)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Alexander S. Farivar, MD, Anton S. McCourtie, MRCS, Brendan C
Volume 58, Issue 2, Pages (August 2000)
Volume 83, Issue 3, Pages (March 2013)
Volume 75, Issue 3, Pages (February 2009)
Volume 66, Issue 6, Pages (December 2004)
Volume 75, Issue 2, Pages (January 2009)
Volume 63, Issue 4, Pages (April 2003)
Volume 87, Issue 2, Pages (February 2015)
Volume 59, Issue 3, Pages (March 2001)
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 4, Pages (February 2008)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 69, Issue 1, Pages (January 2006)
Volume 64, Issue 2, Pages (August 2003)
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells  I. Arany, J.K. Megyesi, B.D. Nelkin,
Volume 62, Issue 5, Pages (November 2002)
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 79, Issue 1, Pages (January 2011)
Fan Zhang, Yaw L. Siow, Karmin O  Kidney International 
Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 5, Pages (November 2003)
Volume 66, Issue 2, Pages (August 2004)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Volume 60, Issue 6, Pages (December 2001)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 84, Issue 3, Pages (September 2013)
Volume 73, Issue 12, Pages (June 2008)
Volume 65, Issue 3, Pages (March 2004)
COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex  Klaus Höcherl, Christoph Schmidt,
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 85, Issue 3, Pages (March 2014)
Volume 68, Issue 2, Pages (August 2005)
Volume 65, Issue 5, Pages (May 2004)
Volume 66, Issue 4, Pages (October 2004)
Volume 83, Issue 6, Pages (June 2013)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 74, Issue 5, Pages (September 2008)
Volume 79, Issue 2, Pages (January 2011)
Andrea Schreiber, Franziska Theilig, Frank Schweda, Klaus Höcherl 
Volume 63, Issue 1, Pages (January 2003)
Volume 65, Issue 6, Pages (June 2004)
Volume 61, Issue 4, Pages (April 2002)
Volume 64, Issue 3, Pages (September 2003)
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Prasun K. Datta, Elias A. Lianos  Kidney International 
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 62, Issue 5, (November 2002)
Suprarenal aortic clamping and reperfusion decreases medullary and cortical blood flow by decreased endogenous renal nitric oxide and PGE2 synthesis 
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Volume 61, Issue 2, Pages (February 2002)
Volume 60, Issue 6, Pages (December 2001)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Presentation transcript:

Volume 64, Issue 5, Pages 1605-1619 (November 2003) The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat  Prabal K. Chatterjee, Nimesh S.A. Patel, Espen O. Kvale, Paul A.J. Brown, Keith N. Stewart, Domenico Britti, Salvatore Cuzzocrea, Helder Mota-Filipe, Christoph Thiemermann  Kidney International  Volume 64, Issue 5, Pages 1605-1619 (November 2003) DOI: 10.1046/j.1523-1755.2003.00254.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Effect of tyrphostin AG126 (Tyr AG126) on glomerular function. (A) Serum creatinine levels and (B) creatinine clearance were measured subsequent to sham operation (sham + saline) or renal ischemia/reperfusion (I/R) (I/R + saline) in the absence or presence of tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to I/R). A separate group of rats received vehicle for tyrphostin AG126 [50% (vol/vol) dimethyl sulfoxide (DMSO)/saline] 30 minutes prior to I/R (I/R + vehicle). *P < 0.05 vs. I/R + saline group, ▪P < 0.05 vs. sham + saline group. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Effect of tyrphostin AG126 (Tyr AG126) on tubular function and injury. (A) Fractional excretion of sodium (FENa) and (B) urinary levels of N-acetyl- β-D-glucosaminidase (NAG) were measured as respective markers of tubular function and injury, subsequent to sham-operation (sham + saline) or renal ischemia/reperfusion (I/R) (I/R + saline) in the absence or presence of tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to I/R). A separate group of rats received vehicle for tyrphostin AG126 [50% (vol/vol) dimethyl sulfoxide (DMSO)/saline] 30 minutes prior to I/R (I/R + vehicle). *P < 0.05 vs. I/R + saline group, ▪P < 0.05 vs. sham + saline group. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Effect of tyrphostin AG126 (Tyr AG126) on reperfusion injury and histologic scoring of renal injury. (A) Serum levels of aspartate aminotransferase (AST) were measured as an indicator of reperfusion injury and (B) renal sections were scored for characteristic histologic signs of renal injury subsequent to sham operation (sham + saline) or renal ischemia/reperfusion (I/R) (I/R + saline) in the absence or presence of tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to I/R). A separate group of rats received vehicle for tyrphostin AG126 [50% (vol/vol) dimethyl sulfoxide (DMSO)/saline] 30 minutes prior to I/R (I/R + vehicle). *P < 0.05 vs. I/R + saline group, ▪P < 0.05 vs. sham + saline group. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Effect of tyrphostin AG126 (Tyr AG126) on the course of renal ischemia/reperfusion (I/R) injury. (A) Serum creatinine levels were measured 24 and 48 hours after renal ischemia in rats subjected to I/R and which were administered either saline [(•) = I/R + saline] or 5 mg/kg tyrphostin AG126 [(○)= I/R + Tyr AG126] 30 minutes prior to ischemia and after 12 hours of reperfusion. Data represent mean ± SEM for N observations. *P < 0.05 vs. I/R + saline group. Histologic examination of kidney sections prepared from rats subjected to ischemia followed by reperfusion for 48 hours and treated with saline (B) displayed more severe renal injury than rats subjected to I/R but which were administered tyrphostin AG126 (C). Hemotoxylin and eosin, original magnification ×125, figures are representative of at least three experiments performed on different days. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Effect of tyrphostin AG126 (Tyr AG126) on inducible nitric oxide synthase (iNOS) expression and nitric oxide production during renal ischemia/reperfusion (I/R). Immunohistochemical localization of iNOS expression in rat kidney sections incubated overnight with primary antibody directed against iNOS [1:500 dilution with phosphate-buffered saline (PBS)] in (A) sham + saline group and (B) I/R + saline group. In comparison, the iNOS expression in kidneys from rats treated with tyrphostin AG126 (5 mg/kg intraperitoneally administered 30 minutes prior to I/R) was markedly reduced (C). Original magnification, ×125/150, figures are representative of at least 3 experiments performed on different experimental days. (D) Effect of tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to I/R) on plasma NO2/NO3 levels subsequent to sham operation (sham + saline) or renal I/R (I/R + saline). A separate group of rats received vehicle for tyrphostin AG126 [50% (vol/vol) dimethyl sulfoxide (DMSO)/saline] 30 minutes prior to I/R (I/R + vehicle). *P < 0.05 vs. I/R + saline group, ▪P < 0.05 vs. sham + saline group. (E) Primary cultures of rat proximal tubular (PT) cells were incubated with incubation medium only (untreated) or with 1mmol/L tyrphostin AG126 only (Tyr AG126 only) or a combination of interferon-γ (IFN-γ) (100 IU/mL) and lipopolysaccharide (LPS) (10 μg/mL) (cytokine only) for 24 hours. PT cells were also incubated with IFN-γ and LPS in the presence of increasing concentrations of tyrphostin AG126 (0.0001 to 1 mmol/L). After 24 hours, levels of NO2/NO3 were measured in the incubation medium. *P < 0.05 vs. CK only group, ▪P < 0.05 vs. untreated group. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Effect of tyrphostin AG126 (Tyr AG126) on cyclooxygenase-2 (COX-2) expression during renal ischemia/reperfusion (I/R). Immunohistochemical localization of the expression of COX-2 in rat kidney sections incubated overnight with primary antibody directed against COX-2 [1:500 dilution with phosphate-buffered saline (PBS)] in (A) sham + saline group and (B) I/R + saline group. In comparison, COX-2 expression in kidneys from rats treated with tyrphostin AG126 (5 mg/kg intraperitoneally administered 30 minutes prior to I/R) was markedly reduced (C). Original magnification, ×125, figures are representative of at least three experiments performed on different experimental days. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Effect of tyrphostin AG126 (Tyr AG126) on nitrotyrosine formation during renal ischemia/reperfusion (I/R). Immunohistochemical localization of nitrotyrosine as an indicator of peroxynitrite formation and/or nitrosative stress (see Discussion section) in rat kidney sections incubated overnight with 1:500 dilution of primary antibody directed against nitrotyrosine in (A) sham + saline group and (B) I/R + saline group. In comparison, the nitrotyrosine immunoreactivity of kidneys from rats treated with tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to renal I/R) was markedly reduced (C). Original magnification, ×150, figures are representative of at least three experiments performed on different experimental days. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 Effect of tyrphostin AG126 (Tyr AG126) on poly (ADP-ribose) (PAR) formation during renal ischemia/reperfusion (I/R). Immunohistochemical localization of PAR formation as an indicator of poly (ADP-ribose) polymerase (PARP) activation in rat kidney sections incubated overnight with primary antibody directed against PAR (1:500 dilution) in (A) sham + saline group and (B) I/R + saline group. In comparison, the PAR immunoreactivity of kidneys from rats treated with tyrphostin AG126 (5 mg/kg administered intraperitoneally 30 minutes prior to renal I/R) was markedly reduced (C). Original magnification, ×125, figures are representative of at least three experiments performed on different experimental days. Kidney International 2003 64, 1605-1619DOI: (10.1046/j.1523-1755.2003.00254.x) Copyright © 2003 International Society of Nephrology Terms and Conditions